These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1103 related articles for article (PubMed ID: 35681225)
21. A novel stemness-hypoxia-related signature for prognostic stratification and immunotherapy response in hepatocellular carcinoma. Zhang G; Zhang K; Zhao Y; Yang Q; Lv X BMC Cancer; 2022 Oct; 22(1):1103. PubMed ID: 36307751 [TBL] [Abstract][Full Text] [Related]
22. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer. Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627 [TBL] [Abstract][Full Text] [Related]
23. Identification of immune related molecular subtypes and prognosis model for predicting prognosis, drug resistance in cervical squamous cell carcinoma. Hu D; Zhang Z; Zhang Y; Huang K; Li X Front Genet; 2023; 14():1137995. PubMed ID: 37007965 [No Abstract] [Full Text] [Related]
24. Systematic Analysis of Tumor Stem Cell-related Gene Characteristics to Predict the PD-L1 Immunotherapy and Prognosis of Gastric Cancer. Wang C; Chen Y; Zhou R; Yang Y; Fang Y Curr Med Chem; 2024; 31(17):2467-2482. PubMed ID: 37936456 [TBL] [Abstract][Full Text] [Related]
25. Tumor microenvironment characterization in colorectal cancer to identify prognostic and immunotherapy genes signature. Guo XW; Lei RE; Zhou QN; Zhang G; Hu BL; Liang YX BMC Cancer; 2023 Aug; 23(1):773. PubMed ID: 37596528 [TBL] [Abstract][Full Text] [Related]
26. Establishment of a circular RNA regulatory stemness-related gene pair signature for predicting prognosis and therapeutic response in colorectal cancer. Chen Q; Tang P; Huang H; Qiu X Front Immunol; 2022; 13():934124. PubMed ID: 35958575 [TBL] [Abstract][Full Text] [Related]
27. Transcriptomic correlates of cell cycle checkpoints with distinct prognosis, molecular characteristics, immunological regulation, and therapeutic response in colorectal adenocarcinoma. Wang H; Wang W; Wang Z; Li X Front Immunol; 2023; 14():1291859. PubMed ID: 38143740 [TBL] [Abstract][Full Text] [Related]
28. Prognostic clinical phenotypes associated with tumor stemness in the immune microenvironment of T-cell exhaustion for hepatocellular carcinoma. Zhang G Discov Oncol; 2023 Nov; 14(1):203. PubMed ID: 37957420 [TBL] [Abstract][Full Text] [Related]
29. Stemness Refines the Classification of Colorectal Cancer With Stratified Prognosis, Multi-Omics Landscape, Potential Mechanisms, and Treatment Options. Liu Z; Xu H; Weng S; Ren Y; Han X Front Immunol; 2022; 13():828330. PubMed ID: 35154148 [TBL] [Abstract][Full Text] [Related]
30. Identification of fatty acid metabolism-related molecular subtype biomarkers and their correlation with immune checkpoints in cutaneous melanoma. Xu Y; Chen Y; Jiang W; Yin X; Chen D; Chi Y; Wang Y; Zhang J; Zhang Q; Han Y Front Immunol; 2022; 13():967277. PubMed ID: 36466837 [TBL] [Abstract][Full Text] [Related]
31. Cross-Talk Between m Song W; Ren J; Xiang R; Yuan W; Fu T Front Immunol; 2022; 13():740960. PubMed ID: 35350786 [TBL] [Abstract][Full Text] [Related]
32. A CLRN3-Based CD8 Gong Z; Huang X; Cao Q; Wu Y; Zhang Q Biomolecules; 2024 Jul; 14(8):. PubMed ID: 39199281 [TBL] [Abstract][Full Text] [Related]
33. Novel hypoxia- and lactate metabolism-related molecular subtyping and prognostic signature for colorectal cancer. Huang A; Sun Z; Hong H; Yang Y; Chen J; Gao Z; Gu J J Transl Med; 2024 Jun; 22(1):587. PubMed ID: 38902737 [TBL] [Abstract][Full Text] [Related]
34. Identification and validation of an anoikis-associated gene signature to predict clinical character, stemness, IDH mutation, and immune filtration in glioblastoma. Sun Z; Zhao Y; Wei Y; Ding X; Tan C; Wang C Front Immunol; 2022; 13():939523. PubMed ID: 36091049 [TBL] [Abstract][Full Text] [Related]
35. Identification of Novel Stemness-based Subtypes and Construction of a Prognostic Risk Model for Patients with Lung Squamous Cell Carcinoma. Shen F; Li F; Ma Y; Song X; Guo W Curr Stem Cell Res Ther; 2024; 19(3):400-416. PubMed ID: 37455452 [TBL] [Abstract][Full Text] [Related]
36. Metabolic Heterogeneity of Tumor Cells and its Impact on Colon Cancer Metastasis: Insights from Single-Cell and Bulk Transcriptome Analyses. Jia Y; Feng G; Chen S; Li W; Jia Z; Wang J; Li H; Hong S; Dai F J Cancer; 2024; 15(13):4175-4196. PubMed ID: 38947396 [No Abstract] [Full Text] [Related]
37. Integrating bulk and single-cell RNA sequencing data reveals epithelial-mesenchymal transition molecular subtype and signature to predict prognosis, immunotherapy efficacy, and drug candidates in low-grade gliomas. Wang C; He Z Front Pharmacol; 2023; 14():1276466. PubMed ID: 38053842 [No Abstract] [Full Text] [Related]
38. A cellular senescence-related classifier based on a tumorigenesis- and immune infiltration-guided strategy can predict prognosis, immunotherapy response, and candidate drugs in hepatocellular carcinoma. Luo Y; Liu H; Fu H; Ding GS; Teng F Front Immunol; 2022; 13():974377. PubMed ID: 36458010 [TBL] [Abstract][Full Text] [Related]
39. Construction of a gene model related to the prognosis of patients with gastric cancer receiving immunotherapy and exploration of COX7A1 gene function. Wang SY; Wang YX; Shen A; Yang XQ; Liang CC; Huang RJ; Jian R; An N; Xiao YL; Wang LS; Zhao Y; Lin C; Wang CP; Yuan ZP; Yuan SQ Eur J Med Res; 2024 Mar; 29(1):180. PubMed ID: 38494472 [TBL] [Abstract][Full Text] [Related]
40. A stemness-based signature with inspiring indications in discriminating the prognosis, immune response, and somatic mutation of endometrial cancer patients revealed by machine learning. Pang X; Wang Y; Zhang Q; Qian S Aging (Albany NY); 2024 Jul; 16(14):11248-11274. PubMed ID: 39079132 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]